News|Videos|July 23, 2026

GLP1s in Dermatology: Emerging Evidence and Unanswered Questions

Author(s)Neal Bhatia, MD, Shanthi Narla, MD, Samip Sheth, MD

Fact checked by: Tim Smith

GLP-1 receptor agonists show early promise for psoriasis and HS, but 3 experts urge caution on mechanism, durability, and long-term safety.

GLP-1 receptor agonists, known primarily for their use among individuals with obesity, overweight, and diabetes, are increasingly being explored for their potential role in dermatology.^1,2,3